Literature DB >> 22036762

The modifying effect of Xmn1-HBG2 on thalassemic phenotype is associated with its linked elements in the beta globin locus control region, including the palindromic site at 5'HS4.

Maryam Neishabury1, Shahbaz Zamani, Azita Azarkeivan, Seyedeh Sedigheh Abedini, Hossein Darvish, Fahimeh Zamani, Hossein Najmabadi.   

Abstract

The core sequence of 5'HS4-beta globin locus control region and Xmn1-HBG2 site were analyzed and compared among 86 thalassemia patients with homozygous or compound heterozygous beta globin gene mutations and 101 normal individuals. Frequency of the G allele in the polymorphic palindromic sequence of 5'HS4 (TGGGG A/G CCCCA) and positive Xmn1-HBG2 profile was significantly higher in thalassemia patients compared to the normal population. Linkage disequilibrium was observed between the G allele and positive Xmn1-HBG2 profile in patient population. Furthermore, dominance of IVSII-1 in the mutation spectrum of the patients enabled us to identify linkage disequilibrium relationships between IVSII-1, positive Xmn1-HBG2 and the G allele at 5'HS4. The frequency of milder clinical phenotype was significantly higher in patients with GG/++ than cases with AA/-- genotypic pattern in 5'HS4/Xmn1-HBG2 loci. These data together with biochemical evidence suggesting a role for the A/G polymorphism at 5'HS4 palindromic site on modifying chromatin structure and in the absence of any evidence from functional studies relating the Xmn1-HBG2 site to the increased gamma chain expression, suggest that the phenotype modifying role long time assigned to Xmn1-HBG2 is possibly played by more functionally potent elements linked to it in LCR.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22036762     DOI: 10.1016/j.bcmd.2011.10.001

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  3 in total

1.  Quantitative Age-specific Variability of Plasma Proteins in Healthy Neonates, Children and Adults.

Authors:  Stefan Bjelosevic; Dana Pascovici; Hui Ping; Vasiliki Karlaftis; Thiri Zaw; Xiaomin Song; Mark P Molloy; Paul Monagle; Vera Ignjatovic
Journal:  Mol Cell Proteomics       Date:  2017-03-23       Impact factor: 5.911

Review 2.  Current and future alternative therapies for beta-thalassemia major.

Authors:  Edouard de Dreuzy; Kanit Bhukhai; Philippe Leboulch; Emmanuel Payen
Journal:  Biomed J       Date:  2016-04-06       Impact factor: 4.910

Review 3.  Molecular genetics of β-thalassemia: A narrative review.

Authors:  Tang-Her Jaing; Tsung-Yen Chang; Shih-Hsiang Chen; Chen-Wei Lin; Yu-Chuan Wen; Chia-Chi Chiu
Journal:  Medicine (Baltimore)       Date:  2021-11-12       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.